Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe

Ameen Abdulla Salahudeen, Manali I. Patel, Paul Baas, Walter J. Curran, Jeffrey D. Bradley, David R. Gandara, Glenwood D. Goss, Tony S. Mok, Suresh S. Ramalingam, Everett E. Vokes, Shakun M. Malik, Heather A. Wakelee

    Research output: Contribution to journalReview articlepeer-review

    4 Scopus citations


    Survival rates of patients with either early and advanced stage non–small-cell lung cancer (NSCLC) have improved with newer systemic therapy and radiation techniques, including combination regimens, targeted therapies, and immunotherapies. The cancer cooperative groups have historically played a critical role in the advancement of NSCLC therapy. Annually, representatives from cooperative groups worldwide convene at the International Lung Cancer Congress (ILCC). In summer 2015, the ILCC reached its 16th anniversary. This article highlights the NSCLC studies presented by participating groups in 2015.

    Original languageEnglish
    Pages (from-to)5-12
    Number of pages8
    JournalClinical Lung Cancer
    Issue number1
    StatePublished - Jan 1 2017


    • Cooperative group
    • Mesothelioma
    • NCTN
    • NSCLC
    • SCLC


    Dive into the research topics of 'Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe'. Together they form a unique fingerprint.

    Cite this